Search

Your search keyword '"Behera, Madhusmita"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Behera, Madhusmita" Remove constraint Author: "Behera, Madhusmita" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
43 results on '"Behera, Madhusmita"'

Search Results

1. Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.

8. MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer

10. P-171 The changing landscape of peri-transplant adverse events with HDT/ASCT and the impact on long term outcomes for myeloma patients

12. Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.

13. Supplementary Figures 1 - 10 from Class I HDACs Are Mediators of Smoke Carcinogen–Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer

14. Data from Class I HDACs Are Mediators of Smoke Carcinogen–Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer

15. Supplementary Table 1 from Class I HDACs Are Mediators of Smoke Carcinogen–Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer

16. Supplementary Figure Legends from Class I HDACs Are Mediators of Smoke Carcinogen–Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer

17. Supplementary Table 2 from Class I HDACs Are Mediators of Smoke Carcinogen–Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer

18. Data from Mcl-1 Interacts with Akt to Promote Lung Cancer Progression

19. Supplementary Table S1 from A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung Cancer

21. Supplementary Figures from A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung Cancer

22. Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis

24. Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma

25. Abstract B085: Shifting sociodemographic characteristics of a phase 1 oncology clinical trial population at an NCI-designated Comprehensive Cancer Center in the Southeast in comparison to its catchment area

28. Comparison of sociodemographic characteristics of a phase 1 clinical trial population at an NCI-designated comprehensive cancer center in the Southeast to catchment area.

29. Molecular testing and patterns of treatment in patients with NSCLC: An IASLC analysis of ASCO CancerLinQ Discovery Data.

30. Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center.

31. Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer

33. Symbolic quantitative cognition in wild zebrafish (Danio rerio)

34. Current and Emerging Informatics Initiatives Impactful to Cancer Registries

36. Contributors

37. Natural history and real-world treatment outcomes for non-small cell lung cancer patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study

39. MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer.

40. The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.

41. Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer-American Society of Clinical Oncology CancerLinQ Study.

42. Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis.

43. Current and Emerging Informatics Initiatives Impactful to Cancer Registries.

Catalog

Books, media, physical & digital resources